Stanford Peng
Geen lopende functies
Profiel
Stanford L.
Peng worked as an Executive Director-Medical at Seagen Inc. from 2014 to 2015.
He also served as a Senior Director at ARYx Therapeutics, Inc. from 2008 to 2009.
In addition, he held the position of Chief Medical Officer & Head-Clinical Development at Stemcentrx, Inc. from 2015 to 2016.
Prior to that, he was the Head-Rheumatology Clinical Research Unit at Benaroya Research Institute at Virginia Mason from 2009 to 2014.
He started his career as an Assistant Professor at Washington University School of Medicine from 2002 to 2005.
Currently, he is the President and Head of Research & Development at Alpine Immune Sciences, Inc. since 2017.
Education: Dr. Peng completed his undergraduate studies at Stanford University.
He obtained his doctorate degree from Yale University and also pursued graduate studies at Yale School of Medicine.
Eerdere bekende functies van Stanford Peng
| Bedrijven | Functie | Einde |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | President | 20-05-2024 |
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2016 |
| SEAGEN INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2015 |
Benaroya Research Institute at Virginia Mason
 Benaroya Research Institute at Virginia Mason Miscellaneous Commercial ServicesCommercial Services Benaroya Research Institute at Virginia Mason is a non-profit organization that operates as a medical research institute. It conducts reserach for eliminating autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis, and immune system diseases such as allergies and asthma. The company was founded in 1956 and is headquartered in Seattle, WA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 |
| ARYX THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-01-2009 |
Opleiding van Stanford Peng
| Yale School of Medicine | Doctorate Degree |
| Stanford University | Undergraduate Degree |
| Yale University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| ARYX THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Benaroya Research Institute at Virginia Mason
Benaroya Research Institute at Virginia Mason Miscellaneous Commercial ServicesCommercial Services Benaroya Research Institute at Virginia Mason is a non-profit organization that operates as a medical research institute. It conducts reserach for eliminating autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis, and immune system diseases such as allergies and asthma. The company was founded in 1956 and is headquartered in Seattle, WA. | Commercial Services |
